About
Luminus Biosciences is a biotech drug development company seeking to transform poorly water-soluble molecules into multidrug nanomedicines. The company develops the Lipid Albumin Solid Nanoparticles (LASSN), a nanotechnology platform that addresses the problems associated with the delivery of water-insoluble drugs such as microtubule inhibitors. Its drug pipeline includes LBI-1103 (LASN -Docetaxel); LBI-0424 (generic Abraxane) for the treatment of cancer. Both drugs are based on the LASSN platform and are in the preclinical stage.uses nanotechnology to remove toxic solvents and carriers to increase the effectiveness of new or existing drugs and decrease the side effect in cancer therapies. It aims to leverage its platform to improve the effectiveness, potency of important drug candidates while reducing the toxicity. It was established in San Antonio, Texas.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 163 investors are based in San Antonio, Texas, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- San Antonio, US
Contact Information
Find more investors like Luminus
Search Investors